PerkinElmer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.11.24	Revvity, Inc. Q3 Profit Increases, Beats Estimates (RTTNews)
29.07.24	Revvity Raises FY24 Earnings Guidance (RTTNews)
29.07.24	Revvity, Inc. Q2 Profit Increases, Beats Estimates (RTTNews)
29.04.24	Revvity, Inc. Q1 Profit Decreases, but beats estimates (RTTNews)
01.02.24	Revvity Initiates 2024 Guidance - Quick Facts (RTTNews)
01.02.24	Revvity, Inc. Announces Fall In Q4 Profit (RTTNews)
30.10.23	Revvity Cuts Annual Outlook Below View (RTTNews)
30.10.23	Revvity, Inc. Announces Fall In Q3 Bottom Line, misses estimates (RTTNews)
01.06.23	Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System (Businesswire)
11.05.23	Revvity Now Sees FY23 Results Below View; To Buy Back $600 Mln Of Shares (RTTNews)
11.05.23	Revvity, Inc. Reveals Increase In Q1 Profit (RTTNews)
14.02.23	PerkinElmer Q4 Profit Decreases, but beats estimates (RTTNews)
08.11.22	PerkinElmer Boosts FY22 Adj. EPS Outlook As Q3 Results Top Estimates (RTTNews)
08.11.22	PerkinElmer Bottom Line Falls In Q3 (RTTNews)
08.11.22	Form 8-K 31791 (RSS)
01.11.22	EPIC SCIENCES EXPANDS EXECUTIVE TEAM AND WELCOMES NEW CHIEF FINANCIAL OFFICER IN PREPARATION FOR RAPID GROWTH (PR Newswire)
17.10.22	PerkinElmer Sees Q3 Adj. EPS To Exceed Prior Guidance (RTTNews)
17.08.22	PerkinElmer CFO Jamey Mock Steps Down; Names Replacement; Backs FY22 View (RTTNews)
17.08.22	Moderna Names James Mock CFO; David Meline To Retire (RTTNews)
01.08.22	New Mountain To Acquire PerkinElmer's Applied, Food Services Businesses For $2.45 Bln (RTTNews)
01.08.22	PerkinElmer Q2 Profit Decreases, but beats estimates (RTTNews)
03.05.22	PerkinElmer Lifts FY22 Outlook (RTTNews)
03.05.22	PerkinElmer Q1 Profit Decreases, but beats estimates (RTTNews)
25.03.22	Form S-3ASR 31791 (RSS)
25.03.22	Form S-8 31791 (RSS)
09.03.22	Form DEF 14A 31791 (RSS)
09.03.22	Additional definitive proxy soliciting materials and Rule 14(a)(12) material (RSS)
16.02.22	Form 4 31791 (RSS)
08.02.22	Form 4 31791 (RSS)
01.02.22	PerkinElmer Guides Q1, FY22 Above Street View (RTTNews)
01.02.22	PerkinElmer Q4 Profit Decreases, but beats estimates (RTTNews)
01.02.22	Form 8-K 31791 (RSS)
11.01.22	PerkinElmer Trading 5% Down (RTTNews)
11.01.22	PerkinElmer Lifts Q4 Adj. Earnings View Above Market (RTTNews)
11.01.22	Form 8-K 31791 (RSS)
23.12.21	Form 4 31791 (RSS)
08.12.21	PerkinElmer Announces Research Use Only Launch Of NEXTFLEX Variant-Seq SARS-CoV-2 Kit V2 (RTTNews)
02.11.21	PerkinElmer Q3 adjusted earnings Beat Estimates (RTTNews)
07.10.21	PerkinElmer Receives FDA Emergency Nod For Respiratory SARS-CoV-2 Panel (RTTNews)
26.07.21	PerkinElmer Boosts FY21 Outlook - Quick Facts (RTTNews)
26.07.21	PerkinElmer Q2 adjusted earnings Beat Estimates (RTTNews)
22.06.21	PerkinElmer To Buy SIRION Biotech (RTTNews)
18.05.21	Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection (GlobeNewswire)
17.05.21	PerkinElmer To Buy Immunodiagnostic Systems In $155 Mln Cash Deal - Quick Facts (RTTNews)
13.05.21	PerkinElmer Buys Nexcelom Bioscience For $260 Mln (RTTNews)
11.05.21	Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency (GlobeNewswire)
04.05.21	PerkinElmer to Host Virtual Investor and Analyst Day (Businesswire)
04.05.21	PerkinElmer Q1 adjusted earnings Beat Estimates (RTTNews)
29.04.21	Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups (GlobeNewswire)
27.04.21	Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Se (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

01.11.24		Handel in New York: Anleger lassen S&P 500 zum Ende des Freitagshandels steigen
01.11.24		Freundlicher Handel: Börsianer lassen S&P 500 am Nachmittag steigen
01.11.24		Börse New York in Grün: S&P 500-Börsianer greifen zu
01.11.24		Börse New York in Grün: S&P 500-Börsianer greifen zum Handelsstart zu
16.10.24		Freundlicher Handel: S&P 500 zum Ende des Mittwochshandels in der Gewinnzone
16.10.24		Mittwochshandel in New York: S&P 500 zeigt sich am Mittwochnachmittag fester

01.11.24

Handel in New York: Anleger lassen S&P 500 zum Ende des Freitagshandels steigen

01.11.24

Freundlicher Handel: Börsianer lassen S&P 500 am Nachmittag steigen

01.11.24

Börse New York in Grün: S&P 500-Börsianer greifen zu

01.11.24

Börse New York in Grün: S&P 500-Börsianer greifen zum Handelsstart zu

16.10.24

Freundlicher Handel: S&P 500 zum Ende des Mittwochshandels in der Gewinnzone

16.10.24

Mittwochshandel in New York: S&P 500 zeigt sich am Mittwochnachmittag fester